These differences need to be better understood to properly determine whether the mechanisms increasing risk for diseases such as AD and related dementias in those carrying one APOE ε4 allele are different from those carrying two, particularly as differential APOE genotype effects may be exacerbated at older ages. This evidence concerns the gene APOE and Alzheimer disease.